ODONATE THERAPEUTICS INC
COM · CUSIP 676079106
0
institutional holders
-8 vs Q1 2022
—reported value*
0 new
0 added
0 reduced
8 sold out
net sold ≈ $7.1m (-5.4m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 90 |
| Q1 2020 | 80 |
| Q2 2020 | 97 |
| Q3 2020 | 90 |
| Q4 2020 | 95 |
| Q1 2021 | 84 |
| Q2 2021 | 70 |
| Q3 2021 | 59 |
| Q4 2021 | 51 |
| Q1 2022 | 8 |
| Q2 2022 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2020 | 64 | 46 |
| Q4 2020 | 59 | 38 |
| Q1 2021 | 47 | 59 |
| Q2 2021 | 28 | 53 |
| Q3 2021 | 18 | 43 |
| Q4 2021 | 29 | 30 |
| Q1 2022 | 0 | 46 |
| Q2 2022 | 0 | 8 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2021 | $150.0k | $228.0k | 1.52 |
| Q4 2021 | $7.0k | $56.0k | 8.00 |
| Q1 2022 | $5.0k | $0 | 0.00 |
| Q2 2022 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| Boxer Capital, LLC | Sold out | -4.2m |
| SAMSARA BIOCAPITAL, LLC | Sold out | -700.4k |
| ACADIAN ASSET MANAGEMENT LLC | Sold out | -385.0k |
| Hennion & Walsh Asset Management, Inc. | Sold out | -69.3k |
| Tower Research Capital LLC (TRC) | Sold out | -43.8k |
| SIMPLEX TRADING, LLC | Sold out | -2.0k |
| BESSEMER GROUP INC | Sold out | -230 |
| NFSG Corp | Sold out | -47 |
Holders, Q2 2022
| Manager | Shares | Change |
|---|